(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 11.03% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.
Evolent Health's revenue in 2025 is $2,054,052,000.On average, 16 Wall Street analysts forecast EVH's revenue for 2025 to be $211,483,622,120, with the lowest EVH revenue forecast at $203,448,360,488, and the highest EVH revenue forecast at $221,639,300,016. On average, 16 Wall Street analysts forecast EVH's revenue for 2026 to be $271,859,685,216, with the lowest EVH revenue forecast at $238,714,230,984, and the highest EVH revenue forecast at $295,407,465,832.
In 2027, EVH is forecast to generate $309,580,774,544 in revenue, with the lowest revenue forecast at $274,314,904,048 and the highest revenue forecast at $338,931,799,672.